BioPharm America 2008

In the recent edition of Pullan Pieces, biotech business development consultant Linda M. Pullan notes the rebound for partnering in the second quarter of this year and then sharpens her focus on the real deals being done.

The following extract is a special feature for Partnering News:  read more 

Six weeks ahead of BioPharm America™, to be held September 9-10 in Atlanta, 60 biotech and start-up companies have been selected to present their innovative technologies and strategies.
Each company will present in 15-minute slots with Next generation Companies being highlighted in a special 7-minute track.  read more 

BioPharm America™ puts a fresh face on partnering for North American executives by hosting the most international Life Sciences partnering event in North America.  read more 

COPENHAGEN, Denmark – Symphogen A/S announced two partnership deals ahead of the summer vacation that leaves the company strongly positioned for the start of business-as-usual in September.
Symphogen announced in June a global strategic collaboration with Genentech, Inc. for antibody therapeutics against three undisclosed infectious disease targets.  read more 

ATLANTA, Ga. -- In partnership with Hospira, Inc, Altea Therapeutics will develop an as yet undisclosed product using the Altea’s proprietary PassPort™ Transdermal Delivery System.  read more 

Navigating a shifting landscape of bio-pharma deal-making will be the focus for discussions among licensing and business development executives from Bayer Schering, Novo Nordisk, Novartis, Pfizer, Johnson & Johnson and Shire Pharmaceuticals at BioPharm America™ in Atlanta, September 9-10, 2008.  read more 

What does it take to support partnering for life sciences on a scale as large and intensive as BioPharm America™ 2008? The partneringONE™ software from EBD Group, which begins to virtually connect BioPharm America participants six weeks ahead of the event.  read more 

“Our claim to fame is making connections,” says John Richert at the North Carolina Biotechnology Center, who is the key contact as Vice President for Business and Technology Development for America’s third-largest biotechnology cluster.

Setting up 30 partnering meetings for a visiting company is one of the most active, and practical examples of what Richert means by making connections.  read more 

Biotech is booming in Georgia, and while the explosive growth of biofuel technologies grabs headlines, the growth in life science biotechnology is no less aggressive, thanks to the determination to mobilize resources towards expanding this sector of the State’s economy.  read more 

Lincolnshire, Illinois (June 10, 2008) – BioSante Pharmaceuticals, Inc. announced that it has engaged Deutsche Bank Securities Inc. as its strategic advisor in connection with the company's ongoing process to explore strategic alternatives in order to maximize value to its stockholders.  read more